Reported 1 day ago
Cathie Wood is making headlines once again with her ARK Innovation ETF (NYSE:ARKK), which has posted a 6% increase this year, outperforming the S&P 500. After a challenging 2024, she remains committed to innovation investments, recently buying 170,778 shares of Beam Therapeutics, now ARK's 20th largest position. Despite mixed reactions from investors and critics regarding ARK's high-risk strategy and speculative growth focus, Wood believes in long-term potential driven by technological advancements.
Source: YAHOO